p53-Independent apoptosis and p53-dependent block of DNA rereplication following mitotic spindle inhibition in human cells

Experimental Cell Research

Volumn 250, Issue 2, 1999, Pages 339-350

  Casenghi, Martina ^a   Mangiacasale, Rosamaria ^a   Tuynder, Marcel ^b   Caillet Fauquet, Perrine ^b   Elhajouji, Azeddine ^c   Lavia, Patrizia ^a   Mousset, Suzanne ^b   Kirsch Volders, Micheline ^c   Cundari, Enrico ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Apoptosis; Cell cycle; Checkpoint; Mitotic spindle inhibitors; P53; Polyploidy

Indexed keywords

CYCLIN B1; DNA; NOCODAZOLE; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CENTROMERE; DNA REPLICATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MITOSIS; MITOSIS SPINDLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TETRAPLOIDY;

EID: 0033178452     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4554     Document Type: Article

References (43)

1. Hartwell L. H., Weinert T. A. Checkpoints: Controls that ensure the order of cell cycle events. Science. 246:1989;629-634.
2. Lane D. P. p53 guardian of the genome. Nature. 358:1992;15-16.
3. Shimamura A., Fisher D. E. p53 in life and death. Clin. Cancer Res. 2:1996;435-440.
4. Bates S., Vousden K. H. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6:1996;12-19.
5. Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
6. Donehower L., Harvey M., Slagle B., McArthur M., Montgomery C., Butel J., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
7. Livingstone L. R., White A., Sprouse J., Livanos E., Jacks T., Tlsty T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 70:1992;923-935.
8. Yonish-Rouach E., Resnitsky D., Lotem J., Sachs K., Kim-Chi A., Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 352:1991;345-347.
9. Lin D., Shields M. T., Ullrich S. J., Appella E., Mercer W. E. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc. Natl. Acad. Sci. USA. 89:1992;9210-9214.
10. Di Leonardo A., Linke S. P., Clarkin K., Wahl G. M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:1994;2540-2551.
11. Allday M. J., Inman G. J., Crawford D. H., Farrell P. J. DNA damage in human B cells can induce apoptosis proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective. EMBO J. 14:1995;4994-5005.
12. Griffiths S. D., Clarke A. R., Healy L. E., Ross G., Ford A. M., Hooper M. L., Wyllie A. H., Greaves M. Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene. 14:1997;523-531.
13. Gorbsky G. J. Cell cycle checkpoints: Arresting progress in mitosis. BioEssays. 19:1997;193-197.
14. Hardwick K. G. The spindle checkpoint. Trends Genet. 14:1998;1-3.
15. Johnson R. T., Downes C. S., Meyn R. E. The synchronization of mammalian cells. Fantes P., Brooks R. The Cell Cycle, A Practical Approach. 1993;1-24 IRL Press, Oxford.
16. Kirsch-Volders M., Cundari E., Verdoodt B. Towards a unifying model for the metaphase/anaphase transition. Mutagenesis. 13:1998;321-335.
17. Norbury C., Nurse P. Animal cell cycles and their control. Annu. Rev. Biochem. 61:1992;441-470.
18. Andreassen P. R., Margolis R. L. Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells. J. Cell Biol. 127:1994;789-802.
19. Trielli M. O., Andreassen P. R., Lacroix F. B., Margolis R. L. Differential Taxol-dependent arrest of transformed and nontransformed cells in the G1 phase of the cell cycle, and specific-related mortality of transformed cells. J. Cell Biol. 135:1996;689-700.
20. Wahl A. F., Donaldson K. L., Fairchild C., Lee F. Y. F., Foster S. A., Demers G. W., Galloway D. A. Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nat. Med. 2:1996;72-79.
21. Cross S. M., Sanchez C. A., Morgan C. A., Schimke M. K., Ramel S., Idzerda R. L., Raskind W. H., Reid B. J. A p53-dependent mouse spindle checkpoint. Science. 267:1995;1353-1356.
22. Sablina A., Iliynskaya G. V., Rubtsova S. N., Agapova L. S., Chumakov P. M., Kopnin B. P. Activation of p53-mediated cell cycle checkpoint in response to micronuclei formation. J. Cell Sci. 111:1998;977-984.
23. Minn A. J., Boise L. H., Thompson C. B. Expression of Bcl-xl and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev. 10:1996;2621-2631.
24. Lanni J. S., Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell Biol. 18:1998;1055-1064.
25. Schimke R. T., Kung A. L., Rush D. F., Sherwood S. W. Differences in mitotic control among mammalian cells. Cold Spring Harb. Symp. Quant. Biol. 56:1991;417-425.
26. Rieder C. L., Khodjakov A. Mitosis and checkpoints that control progression through mitosis in vertebrate somatic cells. Prog. Cell Cycle Res. 3:1997;301-312.
27. Sandberg A. A. Chromosome markers and progression in bladder cancer. Cancer Res. 37:1977;2950-2956.
28. Giaretti W. A model of DNA aneuploidization and evolution in colorectal cancer. Lab. Invest. 71:1994;904-910.
29. Verdoodt B., Castelain P., Bourgain C., Kirsch-Volders M. Aneuploidy of chromosome 1 and overall DNA content in benign and malignant disease. Cancer Genet. Cytogenet. 78:1994;55-63.
30. Telerman A., Tuynder M., Dupressoir T., Robaye B., Sigaux F., Shaulian E., Oren M., Rommelaere J., Amson R. A model for tumor suppression using H-1 parvovirus. Proc. Natl. Acad. Sci. USA. 90:1993;8702-8706.
31. Tuosto L., Cundari E., Gilardini-Montani M. S., Piccolella E. Analysis of susceptibility of mature human lymphocytes to dexamethasone-induced apoptosis. Eur. J. Immunol. 24:1994;1061-1065.
32. Battistoni A., Guarguaglini G., Degrassi F., Pittoggi C., Palena A., Di Matteo G., Pisano C., Cundari E., Lavia P. Deregulated expression of the RanBP1 gene alters cell cycle progression in murine fibroblasts. J. Cell Sci. 110:1997;2345-2357.
33. Elhajouji A., Tibaldi F., Kirsch-Volders M. Indications for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis. 12:1997;133-140.
34. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
35. Lozzio C. B., Lozzio B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 45:1975;321-334.
36. Di Leonardo A., Khan S. H., Linke S. P., Greco V., Seidita G., Wahl G. M. DNA replication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res. 57:1997;1013-1019.
37. Waldman T., Lengauer C., Kinzler K. W., Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature. 381:1996;713-716.
38. Tishler R. B., Lamppu D. M., Park S., Price B. D. Microtubule-active drugs Taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. Cancer Res. 55:1995;6021-6025.
39. Haldar S., Chintapalli J., Croce C. M. Taxol induces Bcl-2 phosphorilation and death of prostate cancer cells. Cancer Res. 56:1996;1253-1255.
40. Haldar S., Basu A., Croce C. M. Bcl2 is the guardian of microtubule integrity. Cancer Res. 57:1997;229-233.
41. Lavia P., Jansen-Dürr P. E2F target genes and cell cycle checkpoint control. BioEssays. 21:1999;221-230.
42. Pei X. F. The human papillomavirus E6/E7 genes induced discordant changes in the expression of cell growth regulatory proteins. Carcinogenesis. 17:1996;1395-1401.
43. King R. W., Deshaies R. J., Peters J. M., Kirschner M. W. How proteolysis drives the cell cycle. Science. 274:1996;1652-1659.